Clinical Trials Browser

Recruiting × Advanced Solid Tumors × WW Domain-Containing Oxidoreductase × Clear all

NCT06726369 2026-05-07

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors